Minot-This, M.-S.; Boudou-Rouquette, P.; Jouinot, A.; de Percin, S.; Balakirouchenane, D.; Khoudour, N.; Tlemsani, C.; Chauvin, J.; Thomas-Schoemann, A.; Goldwasser, F.;
et al. Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients. Pharmaceutics 2022, 14, 1224.
https://doi.org/10.3390/pharmaceutics14061224
AMA Style
Minot-This M-S, Boudou-Rouquette P, Jouinot A, de Percin S, Balakirouchenane D, Khoudour N, Tlemsani C, Chauvin J, Thomas-Schoemann A, Goldwasser F,
et al. Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients. Pharmaceutics. 2022; 14(6):1224.
https://doi.org/10.3390/pharmaceutics14061224
Chicago/Turabian Style
Minot-This, Marie-Sophie, Pascaline Boudou-Rouquette, Anne Jouinot, Sixtine de Percin, David Balakirouchenane, Nihel Khoudour, Camille Tlemsani, Jonathan Chauvin, Audrey Thomas-Schoemann, François Goldwasser,
and et al. 2022. "Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients" Pharmaceutics 14, no. 6: 1224.
https://doi.org/10.3390/pharmaceutics14061224
APA Style
Minot-This, M.-S., Boudou-Rouquette, P., Jouinot, A., de Percin, S., Balakirouchenane, D., Khoudour, N., Tlemsani, C., Chauvin, J., Thomas-Schoemann, A., Goldwasser, F., Blanchet, B., & Alexandre, J.
(2022). Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients. Pharmaceutics, 14(6), 1224.
https://doi.org/10.3390/pharmaceutics14061224
